CoChat

Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors

Open access
Kacen, Assaf, Javitt, Aaron, Kramer, Matthias P., Morgenstern, David, Tsaban, Tomer, Shmueli, Merav D., Teo, Guo Ci, da Veiga Leprevost, Felipe, Barnea, Eilon, Yu, Fengchao, Admon, Arie, Eisenbach, Lea, Samuels, Yardena, Schueler-Furman, Ora, Levin, Yishai, Nesvizhskii, Alexey I., Merbl, Yifat · 2023 · Nature Biotechnology
Cited by 127

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

A computational pipeline identifies tumor antigen post-translational modifications guiding immune responses. Post-translational modification (PTM) of antigens provides an additional source of specificities targeted by immune responses to tumors or pathogens, but identifying antigen PTMs and assessing their role in shaping the immunopeptidome is challenging. Here we describe the Protein Modification Integrated Search Engine (PROMISE), an antigen discovery pipeline that enables the analysis of 29 different PTM combinations from multiple clinical cohorts and cell lines. We expanded the antigen landscape, uncovering human leukocyte antigen class I binding motifs defined by specific PTMs with haplotype-specific binding preferences and revealing disease-specific modified targets, including thousands of new cancer-specific antigens that can be shared between patients and across cancer types. Furthermore, we uncovered a subset of modified peptides that are specific to cancer tissue and driven by post-translational changes that occurred in the tumor proteome. Our findings highlight principles of PTM-driven antigenicity, which may have broad implications for T cell-mediated therapies in cancer and beyond.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41587-022-01464-2

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 127

Metadata

Authors
Kacen, A., Javitt, A., Kramer, M. P., Morgenstern, D., Tsaban, T., Shmueli, M. D., Teo, G. C., da Veiga Leprevost, F., Barnea, E., Yu, F., Admon, A., Eisenbach, L., Samuels, Y., Schueler-Furman, O., Levin, Y., Nesvizhskii, A. I., & Merbl, Y.
Venue
Nature Biotechnology
Published
2022-10-06
Volume
41
Issue
2
Pages
239-251
ISSN
  • 0733-222X (ISSN-L)
  • 1087-0156
  • 1546-1696
OpenAlex
W4302362664
Cited by
127
References
13
FWCI
6.84
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. https://app.cochat.ai/papers/10.1038/s41587-022-01464-2
The paper
Kacen, A., Javitt, A., Kramer, M. P., Morgenstern, D., Tsaban, T., Shmueli, M. D., Teo, G. C., da Veiga Leprevost, F., Barnea, E., Yu, F., Admon, A., Eisenbach, L., Samuels, Y., Schueler-Furman, O., Levin, Y., Nesvizhskii, A. I., & Merbl, Y. (2023). Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nature Biotechnology. https://doi.org/10.1038/s41587-022-01464-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.